Per President Trump, “Under Operation Warp Speed, we’ve shaved years off of the time that it takes to develop a vaccine and we’ve done it while maintaining the FDA gold standard for safety.”
In May, President Trump launched Operation Warp Speed, a groundbreaking partnership between the Federal Government, the scientific community, and the private sector to quickly develop and deliver a safe and effective vaccine and therapeutics. Concurrently, the Operation is also directing a colossal industrial mobilization to facilitate the rapid delivery of an eventual safe vaccine, including manufacturing in parallel with late-stage clinical trials. The project is on track to rapidly-produce 100 million doses as soon as a vaccine is approved – and up to 500 million shortly after.
The Federal Government has already invested over $12 billion in six vaccine candidates, representing multiple pathways toward inducing effective immunity to COVID 19. Agreements with companies including Moderna, Sanofi, GlaxoSmithKline, and Johnson & Johnson will secure hundreds of millions of vaccine doses so vaccines can be available to Americans as quickly as they are approved.
The Trump Administration has also invested billions to dramatically increase the ability of companies to manufacture an eventual vaccine on a massive scale. To aid distribution, the administration has partnered with companies like Corning and SiO2 Materials Science to increase the production of vials, needles and syringes, and more.
Three vaccine candidates are in phase 3 clinical trials, with more following closely behind. Over 140 clinical trials for therapeutics are underway, and effective therapies have already been developed and widely delivered, including remdesivir.
The Food and Drug Administration (FDA) launched its Coronavirus Treatment Acceleration Program to accelerate the development of new treatments for COVID-19 patients. The FDA has also authorized more than 200 tests under emergency authorities, including nearly 170 molecular tests, nearly 40 antibody tests, and 2 antigen tests.
~ Courtesy of AMAC